Recombinant multi-species PSME2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PSME2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. The immunoproteasome contains an alternate regulator, referred to as the 11S regulator or PA28, that replaces the 19S regulator. Three subunits (alpha, beta and gamma) of the 11S regulator have been identified. This gene encodes the beta subunit of the 11S regulator, one of the two 11S subunits that is induced by gamma-interferon. Three beta and three alpha subunits combine to form a heterohexameric ring. Six pseudogenes have been identified on chromosomes 4, 5, 8, 10 and 13. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 11S regulator complex subunit beta (REG-beta),Activator of multicatalytic protease subunit 2,PA28B,PA28b,PA28beta,PA28beta),PSME2,Proteasome activator 28 subunit beta (PA28b,Proteasome activator complex subunit 2,Psme2,REGbeta

Target products collectionGo to PSME2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10567-Ag-1/ GM-Tg-hg-IP10567-Ag-2 Human PSME2 protein Human
GM-Tg-rg-IP10567-Ag-1/ GM-Tg-rg-IP10567-Ag-2 Rat PSME2 protein Rat
GM-Tg-mg-IP10567-Ag-1/ GM-Tg-mg-IP10567-Ag-2 Mouse PSME2 protein Mouse
GM-Tg-cynog-IP10567-Ag-1/ GM-Tg-cynog-IP10567-Ag-2 Cynomolgus/Rhesus macaque PSME2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10567-Ag-1/ GM-Tg-felg-IP10567-Ag-2 Feline PSME2 protein Feline
GM-Tg-cang-IP10567-Ag-1/ GM-Tg-cang-IP10567-Ag-2 Canine PSME2 protein Canine
GM-Tg-bovg-IP10567-Ag-1/ GM-Tg-bovg-IP10567-Ag-2 Bovine PSME2 protein Bovine
GM-Tg-equg-IP10567-Ag-1/ GM-Tg-equg-IP10567-Ag-2 Equine PSME2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10567-Ag-1/ GM-Tg-hg-IP10567-Ag-2; GM-Tg-rg-IP10567-Ag-1/ GM-Tg-rg-IP10567-Ag-2;
GM-Tg-mg-IP10567-Ag-1/ GM-Tg-mg-IP10567-Ag-2; GM-Tg-cynog-IP10567-Ag-1/ GM-Tg-cynog-IP10567-Ag-2;
GM-Tg-felg-IP10567-Ag-1/ GM-Tg-felg-IP10567-Ag-2; GM-Tg-cang-IP10567-Ag-1/ GM-Tg-cang-IP10567-Ag-2;
GM-Tg-bovg-IP10567-Ag-1/ GM-Tg-bovg-IP10567-Ag-2; GM-Tg-equg-IP10567-Ag-1/ GM-Tg-equg-IP10567-Ag-2
Products Name PSME2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PSME2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PSME2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.